Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety risk

Skagit Valley Herald | Mount Vernon

Jul 17, 2023

New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening. Patients given monthly infusions of Eli Lilly and Co.'s donanemab decline…